Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Q: What does CUSIP 152309100 represent in this 13F holders report?

CUSIP 152309100 is the security identifier for CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share used to aggregate holder disclosures.

Q: How many institutions held CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in Q2 2022?

40 institutional investors reported CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 152309100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Ordinary shares, nominal value 0.002 GBP per share
Shares outstanding: 145,993,531
Total 13F shares: 71,775,040
Share change: -2,790,375
Total reported value: $349,577,531
Price per share: $4.87
Number of holders: 40
Value change: -$37,633,222
Number of buys: 20
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 152309100?
CUSIP 152309100 identifies CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 152309100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CNTA - Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Medicxi Ventures Management (Jersey) Ltd	13F 3/4/5	Company · 10%+ Owner	14%	19,963,157	$179,070,000	—	31 Mar 2022	13F 3/4/5
Index Venture Life Associates VI Ltd	13F	Company	6.8%	9,961,789	$89,357,000	—	31 Mar 2022	13F
GENERAL ATLANTIC, L.P.	13F	Individual	6.6%	9,681,818	$86,846,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.8%	5,617,819	$50,406,000	—	31 Mar 2022	13F
Vida Ventures Advisors, LLC	13F	Company	2.7%	3,931,818	$35,268,000	—	31 Mar 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.5%	3,577,094	$32,087,000	—	31 Mar 2022	13F
OUP Management Co., LLC	13F	Company	2%	2,937,615	$26,350,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.7%	2,528,583	$22,681,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	1.7%	2,489,894	$22,334,000	—	31 Mar 2022	13F
Samsara BioCapital, LLC	13F	Company	1.3%	1,884,096	$16,900,000	—	31 Mar 2022	13F
BVF INC/IL	13F	Company	1.2%	1,755,545	$15,747,000	—	31 Mar 2022	13F
Boxer Capital, LLC	13F	Company	0.86%	1,251,137	$11,273,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.77%	1,127,273	$10,112,000	—	31 Mar 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.72%	1,053,142	$9,447,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.62%	907,000	$8,136,000	—	31 Mar 2022	13F
Woodline Partners LP	13F	Company	0.6%	882,633	$7,917,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.5%	727,273	$6,524,000	—	31 Mar 2022	13F
Kynam Capital Management, LP	13F	Company	0.46%	669,100	$6,002,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.42%	616,903	$5,534,000	—	31 Mar 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.35%	517,235	$4,639,000	—	31 Mar 2022	13F
EcoR1 Capital, LLC	13F	Company	0.31%	454,545	$4,077,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	0.31%	454,545	$4,077,000	—	31 Mar 2022	13F
VR Adviser, LLC	13F	Company	0.28%	411,361	$3,690,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.22%	316,601	$2,840,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.21%	304,426	$2,731,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.19%	276,518	$2,481,000	—	31 Mar 2022	13F
Francesco de Rubertis	3/4/5	Director	— class O/S missing	281,162	$2,238,050	—	21 Mar 2022	3/4/5
INDEX VENTURES LIFE VI (JERSEY) L.P.	3/4/5	10%+ Owner	— class O/S missing	149,421	$1,189,391	—	27 May 2021	3/4/5
Affinity Asset Advisors, LLC	13F	Company	0.04%	65,282	$586,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.04%	57,421	$518,512	—	31 Mar 2022	13F
Aaron Kantoff	3/4/5	Director	— class O/S missing	60,000	$477,600	—	18 Nov 2021	3/4/5
Marella Thorell	3/4/5	Chief Accounting Officer	— class O/S missing	53,101	$422,684	—	21 Mar 2022	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	44,177	$396,000	—	31 Mar 2022	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	33,252	$298,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.01%	21,592	$194,000	—	31 Mar 2022	13F
Golden State Equity Partners	13F	Company	0.01%	15,970	$143,000	—	31 Mar 2022	13F
VIRTUS ADVISERS, LLC	13F	Company	0.01%	13,969	$125,000	—	31 Mar 2022	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	11,400	$102,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.01%	10,300	$92,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0%	4,716	$42,000	—	31 Mar 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,245	$11,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1,015	$9,000	—	31 Mar 2022	13F
ADIRONDACK TRUST CO	13F	Company	0%	925	$8,000	—	31 Mar 2022	13F
CITIGROUP INC	13F	Company	0%	911	$8,000	—	31 Mar 2022	13F
Global Retirement Partners, LLC	13F	Company	0%	350	$2,000	—	31 Mar 2022	13F
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC	13F	Company	0%	80	$1,000	—	31 Mar 2022	13F
State of Wyoming	13F	Company	0%	73	$1,000	—	31 Mar 2022	13F

Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) as of Q2 2022

As of 30 Jun 2022, Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,775,040 shares. The largest 10 holders included Medicxi Ventures Management (Jersey) Ltd, Index Venture Life Associates VI Ltd, GENERAL ATLANTIC, L.P., BVF INC/IL, Vida Ventures Advisors, LLC, JANUS HENDERSON GROUP PLC, OUP Management Co., LLC, Cormorant Asset Management, LP, PRICE T ROWE ASSOCIATES INC /MD/, and Samsara BioCapital, LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.